These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26567591)

  • 61. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems.
    Boyd BJ; Whittaker DV; Khoo SM; Davey G
    Int J Pharm; 2006 Feb; 309(1-2):218-26. PubMed ID: 16413980
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate.
    Sassene PJ; Knopp MM; Hesselkilde JZ; Koradia V; Larsen A; Rades T; Müllertz A
    J Pharm Sci; 2010 Dec; 99(12):4982-91. PubMed ID: 20574997
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Advances in the study of lipid-based cubic liquid crystalline nanoparticles as drug delivery system].
    Wu HB; Huo DF; Jiang XG
    Yao Xue Xue Bao; 2008 May; 43(5):450-5. PubMed ID: 18717329
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel steric stabilizers for lyotropic liquid crystalline nanoparticles: PEGylated-phytanyl copolymers.
    Chong JY; Mulet X; Keddie DJ; Waddington L; Mudie ST; Boyd BJ; Drummond CJ
    Langmuir; 2015 Mar; 31(9):2615-29. PubMed ID: 25068381
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Preparation and in vitro embolic efficiency evaluation of hydroxycamptothecine-loaded liquid embolic agent].
    Qin LZ; Zhang X; Wu LN; Zhang J; Pan X; Li G; Wu CB
    Yao Xue Xue Bao; 2014 Jul; 49(7):1069-75. PubMed ID: 25233642
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ionic liquids provide unique opportunities for oral drug delivery: structure optimization and in vivo evidence of utility.
    Williams HD; Sahbaz Y; Ford L; Nguyen TH; Scammells PJ; Porter CJ
    Chem Commun (Camb); 2014 Feb; 50(14):1688-90. PubMed ID: 24394756
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Novel Molecular Reservoir Based on Reverse Self-Assembled Liquid Crystals - A New Strategy for Prolonging the Duration in Action of Analgesics.
    Cao W; Chen J; Wu L; Xu YH; Meng Y; Li X; Zheng Z; Chu X
    J Pharm Sci; 2023 Jul; 112(7):1985-1996. PubMed ID: 37088153
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Monoglyceride Content Affects the Self-Assembly Behavior, Rheological Properties, Syringeability, and Mucoadhesion of In Situ-Gelling Liquid Crystalline Phase.
    Nunes KM; Teixeira CC; Kaminski RC; Sarmento VH; Couto RO; Pulcinelli SH; Freitas O
    J Pharm Sci; 2016 Aug; 105(8):2355-64. PubMed ID: 27339408
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tailoring the internal structure of liquid crystalline nanoparticles responsive to fungal lipases: A potential platform for sustained drug release.
    Poletto FS; Lima FS; Lundberg D; Nylander T; Loh W
    Colloids Surf B Biointerfaces; 2016 Nov; 147():210-216. PubMed ID: 27518452
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lipid cubic phases in topical drug delivery: visualization of skin distribution using two-photon microscopy.
    Bender J; Simonsson C; Smedh M; Engström S; Ericson MB
    J Control Release; 2008 Aug; 129(3):163-9. PubMed ID: 18538886
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.
    Hu L; Sun H; Zhao Q; Han N; Bai L; Wang Y; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():313-24. PubMed ID: 25492202
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The In Vitro Lipolysis of Lipid-Based Drug Delivery Systems: A Newly Identified Relationship between Drug Release and Liquid Crystalline Phase.
    Xiao L; Yi T; Liu Y; Zhou H
    Biomed Res Int; 2016; 2016():2364317. PubMed ID: 27294110
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rational formulation development and in vitro assessment of SMEDDS for oral delivery of poorly water soluble drugs.
    Sprunk A; Strachan CJ; Graf A
    Eur J Pharm Sci; 2012 Aug; 46(5):508-15. PubMed ID: 22521277
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effective in-vivo utilization of lipid-based nanoparticles as drug carrier for carvedilol phosphate.
    Chakraborty S; Shukla D; Vuddanda PR; Mishra B; Singh S
    J Pharm Pharmacol; 2011 Jun; 63(6):774-9. PubMed ID: 21585374
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations.
    Kaukonen AM; Boyd BJ; Porter CJ; Charman WN
    Pharm Res; 2004 Feb; 21(2):245-53. PubMed ID: 15032305
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation.
    Chavanpatil M; Jain P; Chaudhari S; Shear R; Vavia P
    Int J Pharm; 2005 Nov; 304(1-2):178-84. PubMed ID: 16198522
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Liquid crystalline drug delivery vehicles for oral and IV/subcutaneous administration of poorly soluble (and soluble) drugs.
    Otte A; Soh BK; Yoon G; Park K
    Int J Pharm; 2018 Mar; 539(1-2):175-183. PubMed ID: 29371020
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
    Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
    Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.